Dr Rangan ChatterjeeThe Silent Belly Fat Trigger MOST Doctors Miss! | Dr. Pradip Jamandas
CHAPTERS
- 0:00 – 2:48
What fasting does metabolically: switching from glucose to fat-burning
Dr. Jamnadas explains that fasting restores the body’s natural fed–fasted cycle: first using circulating glucose, then glycogen, and eventually stored fat. He outlines the approximate timeline for these transitions and how ketones become a key fuel source during longer fasts.
- •Eating raises insulin and drives energy into storage
- •After ~4–5 hours, the body draws on liver/muscle glycogen
- •By ~18–20 hours, fat stores are mobilized for energy
- •Fat is converted in the liver to ketones for fuel
- •The body is designed for alternating feeding and fasting, not constant intake
- 2:48 – 3:49
Insulin’s central role: why frequent eating keeps the body in storage mode
He argues the modern pattern of frequent eating keeps insulin chronically elevated, preventing fat mobilization. Over time, this leads to insulin resistance, where the body needs more and more insulin for the same effect.
- •Too-frequent meals keep insulin elevated throughout the day
- •Persistently high insulin keeps the body in ‘storage mode’
- •Chronic exposure reduces insulin sensitivity (insulin resistance)
- •Insulin resistance creates a vicious cycle of higher insulin output
- •Modern food availability disrupts the intended hormonal rhythm
- 3:49 – 4:19
A cardiologist’s clue: heart disease with ‘normal’ cholesterol and blood pressure
Dr. Jamnadas describes noticing significant atherosclerosis in patients who didn’t fit the classic risk profile (not diabetic, cholesterol often ‘okay’). This pushed him to look for earlier metabolic warning signs beyond standard labs.
- •Patients presented with angina/heart attacks despite typical markers looking acceptable
- •Cholesterol and blood pressure were often not explanatory
- •He suspected an upstream metabolic driver
- •He began testing sugar regulation more closely
- •This reframed his focus toward early metabolic dysfunction
- 4:19 – 4:49
Finding hidden dysglycemia: impaired glucose tolerance and early intervention
He started identifying mild elevations in glucose (impaired fasting glucose/glucose intolerance) before overt diabetes. He experimented with earlier treatment (e.g., metformin), encountering resistance but observing improved outcomes.
- •Many patients had ‘borderline’ glucose issues rather than diagnosed diabetes
- •Impaired glucose tolerance suggested underlying metabolic stress
- •He trialed metformin to improve insulin sensitivity
- •He faced pushback from physicians and patients
- •Clinical results appeared better with earlier intervention
- 4:49 – 5:40
The Kraft test insight: massive insulin response despite ‘okay’ glucose
By adding insulin testing (Kraft-style testing), he found some patients produced very large insulin spikes even when glucose readings seemed modest. This supported the idea that hyperinsulinemia can precede, and potentially drive, later disease.
- •Oral glucose challenge showed acceptable glucose curves in some patients
- •Insulin measurements revealed disproportionately high insulin secretion
- •High insulin indicated significant insulin resistance
- •Hyperinsulinemia can exist long before diabetes is diagnosed
- •This helped link insulin excess to vascular damage
- 5:40 – 6:24
‘By the time A1C is high, it’s too late’: long lead-time of vascular damage
He explains that years of compensatory high insulin can keep glucose controlled while damage accumulates silently. When glucose finally rises and diabetes is diagnosed, atherosclerosis may already be advanced.
- •The body may need ‘a gallon of insulin’ to keep glucose normal
- •Over time, compensation fails and glucose/A1C rise
- •Vascular damage may have been developing for 15–20 years
- •Diabetes diagnosis can be a late-stage signal, not an early one
- •Lowering insulin becomes a primary therapeutic target
- 6:24 – 7:26
Why fasting became the practical tool: dropping insulin without another drug
Dr. Jamnadas frames fasting as the most direct way to reduce insulin because insulin secretion falls when you’re not eating. Lower insulin then improves insulin sensitivity and reduces the amount needed at the next meal.
- •He sought a method to reliably lower insulin levels
- •Fasting reduces insulin because there’s no incoming food/glucose
- •Lower insulin improves sensitivity for subsequent meals
- •He views fasting as more than weight loss—it's hormonal treatment
- •Metformin may help, but fasting is the most powerful lever in his experience
- 7:26 – 9:21
Hypertension rethought: insulin, nitric oxide, and vessel constriction
He challenges the idea of ‘essential’ (unknown-cause) hypertension by highlighting insulin’s effects on blood vessels. Lowering insulin can restore nitric oxide availability, allowing vessels to dilate and blood pressure to fall.
- •‘Essential hypertension’ often means ‘cause unknown’
- •Insulin can act as a vasoconstrictor by reducing nitric oxide
- •Nitric oxide is crucial for normal vessel dilation and BP regulation
- •Improved nitric oxide dynamics can normalize vascular tone
- •He observed blood pressures drop significantly with fasting
- 9:21 – 10:04
Clinical results: medication reduction and a more effective BP strategy
He reports that when patients lowered insulin through fasting, blood pressures sometimes dropped enough to require stopping or reducing antihypertensive medications. He contrasts this with conventional advice (salt reduction, exercise) which can help but may be less potent alone.
- •Fasting-driven insulin reduction correlated with major BP improvements
- •Some patients needed less blood pressure medication
- •Exercise and salt moderation remain helpful but not the whole story
- •He viewed this as a ‘first time’ durable lever for BP change
- •Mechanism tied back to insulin and nitric oxide
- 10:04 – 10:51
Why weight drops with fasting: ‘unlocking’ fat storage by lowering insulin
He describes insulin as a storage hormone; when insulin falls, stored fat becomes accessible for energy. This hormonal shift, rather than constant calorie restriction, is presented as the key to sustainable fat loss.
- •Insulin promotes storage; low insulin permits fat mobilization
- •Lower insulin removes the ‘padlocks’ on fat stores
- •Fat becomes available for metabolism during fasting
- •He contrasts this with purely calorie-based approaches
- •Weight loss is framed as downstream of hormonal regulation
- 10:51 – 12:37
Aesthetic and adherence differences: fasting vs frequent small meals
He critiques the ‘eat small meals all day’ model, saying it left patients hungry, miserable, and prone to regain. In his observation, fasting produced better well-being and body composition changes, with patients reporting better mood and satisfaction.
- •Very low-calorie, frequent meals often led to misery and hunger
- •Patients commonly regained weight after traditional approaches
- •Fasting patients appeared to lose fat with better overall appearance
- •Higher adherence: patients felt empowered rather than deprived
- •Mood improvements were commonly reported in his clinic
- 12:37 – 16:46
Brain, energy, inflammation, and gut improvements reported during fasting
He shares patient-reported benefits beyond weight and blood pressure: improved mood, alertness, sleep, less pain, and better digestion. He links some of these effects to fasting-induced factors like BDNF and reduced inflammation (e.g., lower CRP).
- •BDNF may increase during fasting, supporting alertness and brain health
- •Patients reported better mood and improved sleep
- •Aches/joint pains improved, suggesting reduced inflammation
- •CRP levels (an inflammation marker) decreased in fasting patients
- •Digestive symptoms improved: less bloating, gas, and post-meal fatigue
